Look for Drugs and Conditions

Cefixime with Sulbactum

Cefixime with Sulbactum

Cefixime with Sulbactam is a combination medication that contains two active ingredients: cefixime, a third-generation cephalosporin antibiotic, and sulbactam, a beta-lactamase inhibitor. This combination is designed to enhance the antibacterial activity of cefixime by protecting it from the action of beta-lactamase enzymes produced by some bacteria.

Indications

Cefixime with Sulbactam is typically prescribed for the treatment of bacterial infections. It is commonly used for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other susceptible bacterial infections.


Dosage

The dosage of Cefixime with Sulbactam varies depending on the specific infection being treated and the patient's age, weight, and overall health. It is essential to follow the prescribed dosage and duration as directed by the healthcare provider.


Contra-Indications

Cefixime with Sulbactam may be contraindicated in individuals with a known allergy or hypersensitivity to cephalosporin antibiotics or beta-lactamase inhibitors. It should not be used in patients with a history of severe allergic reactions to these drugs.


Special Precautions

-Patients with a history of allergic reactions to penicillin or cephalosporins should use this medication with caution. -Individuals with renal impairment may require dosage adjustments. -It is important to complete the full course of treatment, even if symptoms improve before completion.


Side Effects

Common side effects may include gastrointestinal symptoms like nausea, vomiting, diarrhea, and abdominal pain. Allergic reactions such as skin rash and itching are also possible. In rare cases, severe allergic reactions (anaphylaxis) may occur.


Drug Interactions

Cefixime with Sulbactam may interact with other medications, including anticoagulants, probenecid, and certain diuretics. Inform your healthcare provider about all the medications you are taking to avoid potential interactions.


Ad 5